In addition to this oxygen-dependent response, increased HIFa protein levels and/or enhanced transcriptional activity during normoxic conditions can be stimulated by various receptor-med
Trang 1R E V I E W A R T I C L E
The subtle side to hypoxia inducible factor (HIFa) regulation
Rebecca L Bilton and Grant W Booker
Department of Molecular Biosciences, The University of Adelaide, Australia
The transcription factor hypoxia inducible factor a-subunit
(HIFa)is pivotal in the cellular response to the stress of
hypoxia Post-translational modification of HIFa by
hydroxylase enzymes has recently been identified as a key
Ôoxygen sensingÕ mechanism within the cell The absence of
the substrate oxygen prevents the hydroxylases from
modi-fying HIFa during hypoxia and allows dramatic
up-regula-tion of both HIFa protein stability and transcripup-regula-tional
activation capability In addition to this oxygen-dependent
response, increased HIFa protein levels and/or enhanced
transcriptional activity during normoxic conditions can be
stimulated by various receptor-mediated factors such as
growth-factors and cytokines (insulin, insulin-like growth
factor 1 or 2, endothelial growth factor, tumour necrosis
factor a, angiotensin-2) Oncogenes are also capable of
HIFa activation This induction is generally less intense than
that stimulated by hypoxia and although not fully elucida-ted, appears to occur via hypoxia-independent, receptor-mediated signal pathways involving either phosphatidyl -inositol-3-kinase/Akt or mitogen activated protein kinase (MAPK)pathways, depending on the cell-type Activation
of Akt increases HIFa protein synthesis in the cell and results
in increased HIFa protein and transcriptional activity MAPK also activates HIFa protein synthesis and addi-tionally may potentiate HIF1a transcriptional activity via a separate mechanism that does not necessarily require protein stabilization Here we review the mechanisms and function
of receptor-mediated signals in the multifaceted regulation
of HIFa
Keywords: HIFa; growth factor; oncogene; PI3K; MAPK
Introduction
Spurred-on by the discovery of their involvement in the
pathophysiology of many disease states including cerebral
and pulmonary ischemia, cancer tumourigenesis and
malignancy [1], the bHLH-PAS domain-containing hypoxia-inducible transcription factor (HIF)family have become a popular focus for research in the decade since the HIF1a gene was first characterized [2] This family includes the regulatory a-subunits HIF1a and HIF2a that are both able to bind to their constitutively expressed b-subunit, ARNT, to form a functional HIF complex The induction
of HIFa by hypoxia (low physiological levels of oxygen)is dramatic and has been shown to regulate the transcription
of over 40 downstream target genes, including glycolytic enzymes, glucose transporters and vascular endothelial growth factor [3] Regulation of HIFa is complex and involves multiple mechanisms of control at the level of protein degradation and hence protein stabilization, nuclear translocation and transcriptional activation (Fig 1) When stimulated by hypoxia, these mechanisms combine co-operatively to induce maximal HIF activation Recently the Ôoxygen sensorsÕ monitoring this hypoxic response were identified as prolyl- and asparaginyl-hydroxylase enzymes [4–6], which during normoxia (normal physiological levels
of oxygen)mediate the rapid degradation of HIFa protein and prevent transcriptional recruitment of the cofactor CBP/p300, respectively These enzymes and the mechanisms involved in their activation of HIFa upon stimulus by hypoxia are reviewed elsewhere [7,8]
As elucidation of the hypoxic HIFa signalling pathway continues, another side to HIFa biology has quietly emerged Zelzer and coworkers [9] were the first to demonstrate that the growth-factors insulin and insulin-like growth factor-1 (IGF-1)activate HIF1 and that this has subsequently been shown to occur through pathways separate to that employed
by the classical hypoxic pathway (Fig 1) The list of
Correspondence to G Booker, Department of Molecular Biosciences,
The University of Adelaide, North Terrace, Adelaide,
SA 5005, Australia.
Fax: + 61 88303 4348, Tel.: + 61 88303 3090,
E-mail: grant.booker@adelaide.edu.au
Abbreviations: Akt, serine/threonine kinase (also known as protein
kinase B); ARNT, aryl-hydrocarbon receptor nuclear translocation;
bHLH-PAS, basic helix-loop-helix period-ARNT-single-minded;
CBP, CREB binding protein; CO, carbon monoxide; C-TAD,
C-terminal transcriptional activation domain; EGF, epidermal growth
factor; eIF-4E, eukaryotic initiation factor 4E; 4E-BP1, eIF-4E
binding protein 1; FGF-2, fibroblast growth factor-2; FIH-1, factor
inhibiting HIF; FRAP, FKBP(FK506 binding protein)rapamycin
associated-binding protein (also known as mTOR, mammalian target
of rapamycin); HER2NEU, heregulin-2 or EGF stimulated receptor
tyrosine kinase; HGF, hepatocyte growth factor; HIFa, hypoxia
inducible factor-1 or ) 2 a subunit; HRE, hypoxic response element;
IGF-1/IGF-2, insulin-like growth factor-1 or -2; IL-1b, interleukin-1b;
JNK, c-Jun amino-terminal kinase; MAPK, mitogen activated protein
kinase; MEK, MAPK kinase; NO, nitric oxide; p70 S6K , p70 S6 kinase;
PDGF, platelet derived growth factor; PI3K, phosphatidyl-inositol
3-kinase; PTEN, phosphatase and tensin homolog; ROS, reactive
oxygen species; TGF-1b, transforming growth factor-1b; TNFa,
tumour necrosis factor-a; VHL, von Hippel Lindau protein.
(Received 15 October 2002, revised 6 December 2002,
accepted 3 January 2003)
Trang 2receptor-mediated factors that stimulate HIFa currently
includes many growth-factors, cytokines and circulatory
factors such as PDGF, EGF, FGF-2, IGF-2, TGF-1b,
HGF, TNFa, IL-1b, angiotensin-2 and thrombin [10–16] In
addition, oncogenes (HER2NEU, Ras, v-Src)[17–19], and
mutations in the tumour suppressor PTEN [20], have also
been shown to affect HIF1a activity through these same
signalling pathways Other HIFa stimuli include signalling
intermediates such as NO [21,22] and the in vitro phenomena
of cell culture confluence [22,23]
While the degree of observable HIFa protein or
tran-scriptional activation varies with each stimulus and cell-type
[9,22,24], as a generalization, the magnitude of the
receptor-mediated HIFa response in vitro is far less than the dramatic
induction caused by hypoxia Treatment of L8 or ARPE
cells with insulin for example, results in twofold to sixfold
inductions of an HRE-luciferase reporter [9,24] (Fig 2) An
exception to this trend, however, can be found in vascular
smooth muscle cells, where several stimulatory factors
increased the amount of protein observed to levels
signifi-cantly greater than those induced by hypoxia [13] Whilst
apparently minor in comparison to the in vitro induction by
hypoxia, the gene expression changes resulting from the
receptor-mediated pathways are nonetheless important
These stimuli often elicit small changes in housekeeping
functions that accumulate over extended periods of time [25]
Receptor-mediated HIFa regulation has been shown to
occur via two well characterized signalling pathways, the
Ras/MEK/MAPK and PI3K/Akt/FRAP kinase cascades
[24,26,27] (Fig 3) Although the end result is enhanced
HIFa protein levels and/or transcriptional activation even
under normoxic conditions, the molecular mechanisms
involved must differ from those of hypoxia, as low oxygen
tension and activation of the MAPK and Akt pathways can
co-operate to enhance the induction of HIFa activity [20,
27–29] There is some evidence to suggest that co-operation
of these kinase pathways with hypoxia may occur via the hypoxic generation of reactive oxygen species (ROS)as an intermediate signalling step [30] (reviewed in [31]) This may also be the pathway by which some of the stimulatory factors such as thrombin, angiotensin and IL-1b influence HIFa, as their ability to activate HIF1a was blocked by ROS inhibitors and antioxidants [13,14,32] In this way,
Fig 2 Fold induction of pTK-HRE luciferase reporter construct in stably transfected 3T3L1 adipocyte cells Treatments include dipyridyl (100 n M ), serum free, insulin (100 n M ), IGF-1 (5 n M )and IGF-2 (5 n M ) Data normalized using pTK-Renilla construct as a transfection control.
Fig 3 Schematic representation of the molecular interactions controlling receptor-mediated signals leading to HIFa dependent transcription of downstream target genes Arrows indicate activating steps, truncated arrows indicate inhibitory effects and dotted lines indicate possible interactions for which only limited evidence is available.
Fig 1 Schematic overview of the receptor-mediated and hypoxic signal
pathways and the mechanisms they employ to activate HIF and induce
transcription of downstream target genes The larger arrow highlights
the greater magnitude of the response derived from hypoxic signals
relative to receptor-mediated signals.
Trang 3ROS may then recruit the MAPK or Akt pathways to
activate HIFa via ligand-independent activation of various
growth-factor receptors, such as the EGF receptor [33]
To add further complexity to normoxic HIFa regulation,
the particular kinase pathway employed and its action upon
HIFa may differ depending on cell type or specific stimulus
It is important to remember that different cell-types may
express a different combination of signalling proteins and
may therefore respond to the same stimuli to a lesser or
greater extent This includes the Akt and MAPK pathways,
which are not always active in every cell type [34] The use of
different pathways occurs in the hepatoma cell-line HepG2
where both TNFa and IL-1b were shown to increase DNA
binding by HIF, but only IL-1b was able to increase the
observed HIF1a protein levels [12] This suggests a different
mechanism of action for each cytokine in this cell type In
contrast to these findings, the two cytokines were reported
to act in the same manner to increase transcription of
HIF1a mRNA by twofold to threefold resulting in increased
protein levels in synovial fibroblasts [16] Furthermore, the
differences in stimuli-induced signalling are highlighted by
the example of IGF-1 stimulation in different cell types
IGF-1 stimulation allows visualization of HIF1a protein
and increases transcriptional activity of HIF1a via
activa-tion of MAPK in mouse embryo fibroblasts [35], whereas in
the U373 glioblastoma cell line these effects require Akt [20]
Both kinase pathways are reported to additively increase
HIF1a translation and thus protein level in HCT116 colon
carcinoma cells [26] Finally, the family members HIF1a
and HIF2a are both responsive to receptor-mediated
stimuli, but not necessarily the same stimuli within a single
cell type, even when both homologues are coexpressed [29]
Whilst confusing, this complexity and cross-talk between
signalling pathways is not uncommon for growth factor
stimuli Dependant on cell type and signal intensity,
stimulation of receptors by insulin can alternatively activate
either MAPK or Akt, and this can result in the completely
disparate outcomes of proliferation (mitogenic)or glucose
uptake (metabolic)[34]
Phosphorylation
Upon polyacrylamide gel electrophoresis, HIFa protein
migrates as a diffuse band consistent with an approximate
20 kDa increase in molecular mass from its predicted size of
104 kDa [14,36,37,41] This broad band contains
phos-phorylated species of HIFa, as treatment with a
phospha-tase returns the protein to its predicted size [41] Several
deletion studies have failed to identify specific residues,
which when phosphorylated, alter hypoxic induction of
HIF1a [4,5,38] However, a report from Gradin et al [39]
suggests the presence of an oxygen-independent,
ubiqui-tously phosphorylated residue that may play a role in
providing structural support to the active protein Although
phosphorylation was not shown directly, mutational
ana-lysis identified the threonine residue 844 of HIF2a, located
near the hydroxylase targeted asparagine 851, as being
important for the function of the C-terminal transcriptional
activation domain (C-TAD), spanning residues 824–874,
regardless of the oxygen state Phosphorylation or
intro-duction of a negatively charged residue at position 844
allows binding of CBP in a mammalian two-hybrid system
[39] It is feasible that phosphorylation of other residues also act in a similar manner to stabilize HIFa postinduction and this may efficiently maintain the structure of the newly formed active transcriptional complex Support for this proposal is provided by the finding that HIFa is phosphor-ylated postinduction after a short lag period of up to a minute [40] The kinase(s)and upstream regulatory signals involved in either ubiquitous or stimuli-induced phosphory-lation have not yet been fully elucidated
MAPK Direct phosphorylation of HIFa by MAPK has been reported by several groups These researchers showed that activated recombinant or endogenous MAPK was able to phosphorylate either full-length HIFa or a C-TAD-fusion product when supplied as a substrate [27,41,42] In those studies employing HIF1a-fusion proteins expressed in COS-7 cells, the region targeted by MAPK was shown to lie within residues 786–826 of the C-TAD [27] or residues 531–826 spanning both the inhibitory domain and C-TAD [42] Although Sodhi et al [42] identified up to eight serine residues within this inhibitory region that contain adjacent proline residues that may serve as putative consensus target sites for the MAPK family, the specific HIFa residue(s)that are phosphorylated by MAPK have yet to be identified A proposed function for phosphorylation leading to increased HIF transcriptional activity is through the derepression of the inhibitory domain that lies between the two transcrip-tional activation domains of the HIF a-subunit [42] Regions within this inhibitory domain have been shown
to be important for the interaction of HIFa with factor inhibiting HIF-1 (FIH-1)[43,44] identified as the asparagine hydroxylase [45] In the three-dimensional structure, these regions may form part of the FIH-1 recognition site One possible explanation for the observed derepression of the HIFa inhibitory domain, is that phosphorylation of residues within this domain may prevent docking of FIH, and thus prevent the subsequent asparagine hydroxylation This would result in a derepression of transcriptional activity, as CBP/p300 would be able to associate with HIFa
As mentioned previously, hypoxia is able to activate MAPK in some cell lines [27–29] However, activation of MAPK in hypoxia is not necessarily required for HIF1a activation and this appears dependent on cell-type In fibroblasts, MAPK activation was blocked by application
of the MEK inhibitor PD 098059 and yet the activation of HIF1a induced by hypoxia remained unaffected [35] In contrast, it was found that PD 098059 treatment of HT42 and Rat-1 fibroblast cell-lines moderately decreased HIF transcriptional activity in both normoxia and hypoxia [18,36] It is possible that the reduction in HIF transcrip-tional activity in these latter studies was due to inhibition of MAPK activity that may have been stimulated by factors present in the culture media Indeed, HIF transcriptional ability induced by receptor-mediated stimuli is impaired when the MEK chemical inhibitors PD 098059 and U0126,
or dominant-negative MAPK mutants were applied to cells
in culture [18,29] Other kinase family members such as the stress kinases p38a, p38c and JNK have also been shown to
be involved in signalling to HIFa in several cell-types [42] In most reports documenting a role for MAPK in HIF
Trang 4function, no change to the observable level of HIFa protein
expression, protein stability, rate of protein degradation or
DNA-binding ability were observed [27,29,41] This
indi-cates that effects due to MAPK signalling, in most cell-types
studied to date, do not precede HIFa protein expression or
stabilization and instead improve HIF transcriptional
activity Possibilities for MAPK action upon HIF
tran-scriptional ability include recruitment of cofactors to the
active transcriptional complex, or a direct MAPK
phos-phorylation of HIFa residue(s) Phosphos-phorylation may
improve HIF transcriptional activity by derepression of
the HIFa inhibitory domain or simply favouring a
confor-mation that supports the active domain Given the
varia-tions encountered so far within the characterization of the
receptor-mediated signalling pathway, it is not
surpri-sing that, in a few cell types, the up-regulation of HIF
transcriptional activity via MAPK activity has been
attri-buted to an increase in observable HIF1a protein [22,24] In
this way, MAPK may act via a similar mechanism to Akt to
improve HIFa protein synthesis The effects of MAPK on
protein stability or transcriptional activation need not
necessarily be mutually exclusive
Akt
The serine/threonine kinase Akt has also been identified as a
signalling intermediate downstream of the
receptor-medi-ated factors that alter HIFa regulation Unlike stimulation
by MAPK, Akt activity increases HIF transcriptional
activation by increasing the pool of available HIFa protein
within the cell The use of chemical inhibitors such as
wortmannin and LY 294002 that block the
phosphatidyl-inositol 3-kinase (PI3K)family of enzymes, or dominant
negative mutants of the PI3K/Akt pathway were shown to
inhibit factor- or hypoxia-stimulated HIF1a protein
accu-mulation as detected by Western blot [10,46] A reduction in
the levels of observable HIFa protein resulted in loss of
DNA binding ability of HIF and failure to up-regulate the
transcription of reporter constructs or endogenous
down-stream target genes [10,46] Similarly over-expression of
members of the PI3K/Akt pathway or inhibition of PTEN,
a negative regulator of Akt, resulted in increased levels of
HIF1a protein, DNA binding or transcriptional activity in
many cell types [18,20] (Fig 3) It was initially proposed
that the observed increase in HIFa protein was due to
enhanced stability, possibly through inhibition of the
proteosomal degradation machinery that is active in
norm-oxic conditions [20,28]
Recently several publications have clarified the role that
Akt plays in HIFa biology, linking an Akt signal to an
increased rate of HIFa protein synthesis [17,24,26] When
stimulated by heregulin, IGF-1 or insulin, activation of the
PI3K/Akt/FRAP pathway was shown to increase de novo
protein synthesis, as shown by inhibition with the
transla-tion inhibitor cycloheximide and pulse chase experiments
[17,24,26] FRAP, also known as mTOR, de-represses the
translational regulatory protein eIF-4E by phosphorylating
and inactivating its binding protein 4E-BP1 [25] FRAP also
activates p70S6Kwhich in turn is able to activate the 40S
ribosomal protein S6 [25] (Fig 3) Thus in a wortmannin-,
LY 294002- and rapamycin-sensitive manner, activation of
eIF-4E and p70S6Kresults in the increased translation from
HIF1a mRNA [17,24,26] Interestingly, Fukuda et al identified a novel role for MAPK in HCT116 cells as its activation was also shown to alter HIF1a protein synthesis [26] Unlike other reports (see above)that document enhanced HIF transcriptional activity upon MAPK stimu-lation with no alteration to HIFa protein levels, activation
of MAPK in these cells was shown to lead to a transient activation of eIF-4E and its effects on HIF1a protein synthesis were additive to those of PI3K/Akt/FRAP [26] (Fig 3) Enhanced levels of HIFa synthesis may explain the previous reports for which activation of MAPK resulted in
an increase in observed HIFa protein levels [22,24] The increase in HIFa protein synthesis appears to be relatively gene specific since the translation of control luciferase-reporter or ARNT mRNA was not altered [17] In addition, over-expression of both FRAP and eIF-4E have been previously shown to disproportionately increase the trans-lation of specific target genes [25,47] This mechanism of increased translation is in contrast to that employed by hypoxic stimuli for which it has been repeatedly shown, for most cell types, that there is no alteration of either HIFa mRNA levels or the rate of de novo protein synthesis when oxygen levels are limiting [17,48]
Increased translation of HIFa mRNA ultimately leads to
an increase in the HIFa protein pool, thus explaining initial reports that observed increased HIFa protein in response to stimulatory factors Given that the prolyl (and presumably the asparaginyl)hydroxylase enzymes are believed not to be
at high concentrations within the cell [49], increasing the availability of their HIFa substrate may easily titrate them out As well as overwhelming the HIFa degradation mechanisms, substrate saturation also relieves the transcrip-tional repression due to the asparagine hydroxylase, FIH-1 Thus it is plausible that even small increases in total HIFa protein via up-regulated translation could saturate one or both of these enzymes Overwhelming the hydroxylase enzymes may enable a small portion of the total HIFa protein translated to escape the normoxic suppression and degradation pathways The presence of even a small amount
of active protein will result in some HIF-target gene transcription, although the level of down-stream target genes transcribed may be much less than the maximal inductions possible in hypoxia [9,14] Although receptor-mediated signals have been shown to significantly improve the observable levels of HIFa protein and/or ability to bind DNA [13,24], this does not necessarily always correlate with large increases in transcriptional activation In addition, over-expressed HIFa protein is not fully activated in normoxia [50] This lack of full transcriptional activity, even in the presence of high levels of protein, could be either because cofactors are limiting in these cells, or that there are differences in the substrate saturation levels between the different hydroxylases In concluding this section on the mechanism(s)of action of PI3K/Akt, it must be noted that although induction of the PI3K/Akt/FRAP pathway played no role in alteration of HIF1a ubiquitination, VHL interaction, proteosomal-degradation or protein sta-bility in ARPE-19, MCF-7 or HCT116 cell lines [17,24,26], up-regulated translation may not be the only mechanism for protein stabilization in all cell types Inhibition of HIFa protein degradation, possibly by interruption of the hydroxylase function, cannot yet be ruled out as a
Trang 5mechanism of action for some receptor-mediated stimuli.
Recently, Chan and coworkers (2002)have shown that
HIFa protein was increased by expression of the v-Src and
RasG12V onco-proteins, as well as constitutively active
Akt, however, there were variations in the amount of HIFa
proline-hydroxylation detected for each stimulus [51] The
antibody generated during this work, which targets the
hydroxylated proline 564 of HIF1a (531 of HIF2a)[51], will
prove a valuable tool in delineating the exact hydroxylation
status of HIFa protein during all types of stimuli
Nitric oxide, carbon monoxide and cell
confluence
Nitric oxide (NO)has been shown to increase HIFa protein
levels, DNA binding and transcriptional activity in
endo-thelial, smooth muscle, Hep3B and LLC-PK1cells during
normoxia [21,52] Paradoxically, it has also been reported
that NO can also have the completely opposite effect
of inhibition of both basal- and hypoxia-induced expression
of HIF target genes in endothelial cells [53] Inhibition of
hypoxia-induced DNA-binding activity by carbon
monox-ide (CO)or NO exposure was also seen in several other cell
types [54,55], although reduced HIFa protein expression
was only observed in one case [55] These inhibitory effects
may be stimuli specific as CO did not prevent the
stabilization of HIF1a protein and transcriptional activity
induced by either cobalt chloride or the iron-chelator
desferrioxamine [55] The differences in these findings
indicate that cell type, concentration of NO or CO stimuli
and cellular oxygen status are important experimental
considerations and suggest that CO and NO may mediate
their effects through multiple targets within the HIF
pathway, possibly dependent on their concentration To
further complicate matters, the genes that produce these NO
and CO species, inducible-nitric oxide synthase and heme
oxygenase, are regulated by HIF [56,57] and the
growth-factor insulin is able to stimulate NO production via a
PI3K-dependant pathway [58] Although the mechanism(s)
via which NO or CO affect HIF remain unclear, one
proposal is that they bind to the hydroxylase enzymes [59],
and activate HIF in normoxia [53] As analogues of
molecular oxygen, they may bind to hydroxylases but not
participate in the hydroxylation reaction Thus in normal
oxygen conditions, the activity of hydroxylases, and thus
protein degradation may be prevented [59] However, this
cannot explain how in low oxygen concentrations, during
hypoxia, NO or CO are able to prevent the hypoxic
stabilization and activation of HIFa [53]
Nitric oxide was identified as a signalling intermediate
between HIF and the stimulus of increased cell confluence
[22] When the density of prostate cells in culture was
increased, levels of HIF1a protein increased concomitantly
via a nitric oxide and Ras/MAPK dependant signalling
pathway [22] In addition, increased transcription of the
HIF target gene vascular endothelial growth factor was
observed in dense cultures of human glioblastoma cells
(U87)and fibrosarcoma cells (HT1080)[23] This is in
contrast to several findings which document a decrease in
HIF1a protein expression and consequently reduced DNA
binding activity in prostate cancer cells grown at high
density (90%)compared to low density (50%)during both
hypoxic and normoxic conditions [10,60] It also conflicts with the finding that stimulation of HIF1a by insulin was only possible when cells were cultured at low density [11] that suggests the capacity for induced up-regulation of HIFa is prevented at high density Given these completely disparate results, there can be no consensus currently made
as to a mechanism for cell-density mediated effects on HIFa and clearly this area requires more research However, the phenomenon of confluence is an important consideration during in vitro cell-based assays, particularly because the effects of confluence may be due in part to localized hypoxia Confluence should be carefully monitored during analysis of HIFa activation by each nonhypoxic stimulus so the mechanism by which that stimulus contributes to HIFa can be clearly defined Finally, the contribution that density makes to HIFa activity in vivo within tissues is unknown Possibly it forms part of the basal level of HIF activity and this may be different in each tissue type, depending on how tightly packed the cells are Although HIFa is ubiquitously expressed within all cells, the level of normoxic HIFa protein observable and also the capacity for inducible up-regulation varies in different cell types [61]
A role for receptor-mediated HIFa in vivo ? HIFa is a transcription factor with a complex set of multiple regulatory mechanisms Activation through various recep-tor-mediated pathways, to influence only a subset of these regulatory mechanisms, allows for a moderate induction of HIFa and consequently a small increase in the transcription
of downstream target genes Given the subtle effect upon HIFa, it is likely that receptor-mediated signalling during normoxia plays a secondary role to the induction of HIFa
by hypoxia It appears more than a coincidence that genes encoding a number of components of the receptor-mediated signal pathways are themselves regulated by HIFa or hypoxia Inducible nitric oxide synthase [56] and haem oxygenase-1 [57] contain HRE within their promoters, whilst other genes, IGF-2 [11], IGF binding proteins-2 and -3 [11], PDGF [62], FGF [63] and TGF-1b [64] may be indirectly altered by hypoxia or HIF With this complex web of autoregulatory feedback, it would seem reasonable
to propose that receptor-mediated activation of HIFa has
a role in vivo, and is not just an in vitro cell culture phenomenon
What is the role of receptor-mediated activation of HIFa? One proposal is that these signals may be important for stimulation of HIFa for oxygen-independent purposes and they may also act to enhance hypoxic activation in some tissue types There are many situations where expression of HIF target genes may provide a biological advantage other than just hypoxic stress Receptor-mediated signals may increase the transcription of only a subset of the HIF responsive genes during this time These situations may include cell proliferation, differentiation, development or inflammatory responses All of these biological activities would place an increased Ômetabolic loadÕ on a cell above its normal metabolic requirements, and interestingly, these are processes which are often stimulated by, or result in, the expression of growth-factors and cytokines known to activate HIFa For example, HIF1a is one of many genes whose expression is up-regulated during adipogenesis [65]
Trang 6and IGF-2 levels are extremely high in embryogenesis [66].
Interestingly, HIF1a has been shown to be stabilized and
activated by the cytokine TNFa during inflammation in
normoxic wounds, allowing increased expression of the HIF
target-gene vascular endothelial growth factor in order to
promote wound healing [67] It is possible that these
receptor-mediated effects, particularly through HIFa protein
synthe-sis, are only able to occur in active tissues, especially because
the translation initiation factor eIF-4E is only abundant in
nonquiescent cells [25] Stimulation of HIFa though
oxygen-independent mechanisms could increase expression of genes
that promote angiogenesis, vasodilation, glucose uptake or
glycolysis to provide increased nutrient supply to those
tissues requiring it Many of these HIF target genes have
other regulatory elements within their promoters and their
expression is a balance between converging signals This may
be the case with many of the glycolytic genes such as
hexokinase that have glucose or carbohydrate responsive
elements nearby to the hypoxic response elements that may
combine synergistically to regulate gene expression [68,69]
Further work is required to clarify the molecular details of
the receptor-mediated signalling pathways and their different
effects on HIFa activity However the activation of HIFa by
receptor-mediated signals has been established It will also be
important to define the role(s)for these signalling pathways
and to investigate the possibility that this type of
receptor-mediated induction of HIFa may regulate the transcription
of only a subset of HIF responsive genes for specific functions
like regulating the metabolic load of highly active cells
Acknowledgements
Rebecca Bilton funded by an Australian Postgraduate Award (APA)
and a CSIRO Postgraduate scholarship Funding from the CSIRO/
Adelaide University Nutrition Trust is gratefully acknowledged With
thanks to Dr D Peet for critical reading of this manuscript.
References
1 Semenza, G.L (2002)HIF-1 and tumor progression:
pathophysiology and therapeutics Trends Mol Med 8, S62–S67.
2 Wang, G.L., Jiang, B.H., Rue, E.A & Semenza, G.L (1995)
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension Proc Natl Acad.
Sci USA 92, 5510–5514.
3 Semenza, G.L (2001)Hypoxia-inducible factor 1: oxygen
homeostasis and disease pathophysiology Trends Mol Med 7,
345–350.
4 Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M.,
Salic, A., Asara, J.M., Lane, W.S & Kaelin, W.G Jr (2001)
HIFalpha targeted for VHL-mediated destruction by proline
hydroxylation: implications for O2 sensing Science 292, 464–468.
5 Jaakkola, P., Mole, D.R., Tian, Y.M., Wilson, M.I., Gielbert, J.,
Gaskell, S.J., Kriegsheim, A., Hebestreit, H.F., Mukherji, M.,
Schofield, C.J., Maxwell, P.H., Pugh, C.W & Ratcliffe, P.J (2001)
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation
complex by O 2 -regulated prolyl hydroxylation Science 292,
468–472.
6 Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J & Whitelaw,
M.L (2002)Asparagine hydroxylation of the HIF transactivation
domain a hypoxic switch Science 295, 858–861.
7 Semenza, G.L (2001)HIF-1, O( 2 ), and the 3 phds: how animal
cells signal hypoxia to the nucleus Cell 107, 1–3.
8 Lando, D., Gorman, J.J., Whitelaw, M.L & Peet, D.J (2003) Oxygen-dependent regulation of the hypoxia-inducible factors
by prolyl and asparaginyl hydroxylation Eur J Biochem 270, 781–790.
9 Zelzer, E., Levy, Y., Kahana, C., Shilo, B.Z., Rubinstein, M & Cohen, B (1998)Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1a/ARNT EMBO J.
17, 5085–5094.
10 Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M.M., Simons, J.W & Semenza, G.L (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/ AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics Cancer Res 60, 1541–1545.
11 Feldser, D., Agani, F., Iyer, N.V., Pak, B., Ferreira, G & Semenza, G.L (1999)Reciprocal positive regulation of hypoxia-inducible factor 1a and insulin-like growth factor 2 Cancer Res.
59, 3915–3918.
12 Hellwig-Burgel, T., Rutkowski, K., Metzen, E., Fandrey, J & Jelkmann, W (1999)Interleukin-1b and tumor necrosis factor-a stimulate DNA binding of hypoxia-inducible factor-1 Blood 94, 1561–1567.
13 Richard, D.E., Berra, E & Pouyssegur, J (2000)Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells J Biol Chem 275, 26765–26771.
14 Gorlach, A., Diebold, I., Schini-Kerth, V.B., Berchner-Pfann-schmidt, U., Roth, U., Brandes, R.P., Kietzmann, T & Busse, R (2001)Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22 (phox)-containing NADPH oxidase Circ Res 89, 47–54.
15 Tacchini, L., Dansi, P., Matteucci, E & Desiderio, M.A (2001) Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1)activity in HepG2 hepatoma cells Carcinogenesis 22, 1363–1371.
16 Thornton, R.D., Lane, P., Borghaei, R.C., Pease, E.A., Caro, J & Mochan, E (2000)Interleukin 1 induces hypoxia-inducible factor
1 in human gingival and synovial fibroblasts Biochem J 350, 307–312.
17 Laughner, E., Taghavi, P., Chiles, K., Mahon, P.C & Semenza, G.L (2001)HER2 (neu)signaling increases the rate of hypoxia-inducible factor 1a (1a)synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol Cell Biol 21, 3995–4004.
18 Chen, C., Pore, N., Behrooz, A., Ismail-Beigi, F & Maity, A (2001)Regulation of glut1 mRNA by hypoxia-inducible factor-1 Interaction between H-ras and hypoxia J Biol Chem 276, 9519–9525.
19 Jiang, B.H., Agani, F., Passaniti, A & Semenza, G.L (1997) V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression Can Res 57, 5328–5335.
20 Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A.R., Ryan, H.E., Johnson, R.S., Jefferson, A.B., Stokoe, D & Giaccia, A.J (2000)Loss of PTEN facilitates HIF-1-mediated gene expression Genes Dev 14, 391–396.
21 Sandau, K.B., Faus, H.G & Brune, B (2000) Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3K pathway Biochem Biophys Res Commun 278, 263–267.
22 Sheta, E.A., Trout, H., Gildea, J.J., Harding, M.A & Theodorescu, D (2001)Cell density mediated pericellular hypoxia leads to induction of HIF-1a via nitric oxide and Ras/MAP kinase mediated signaling pathways Oncogene 20, 7624–7634.
Trang 723 Mukhopadhyay, D., Tsiokas, L & Sukhatme, V.P (1998)High
cell density induces vascular endothelial growth factor expression
via protein tyrosine phosphorylation Gene Expr 7, 53–60.
24 Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G.L &
Van Obberghen, E (2002)Insulin stimulates hypoxia-inducible
factor 1 through a phosphatidylinositol 3-Kinase/Target of
rapamycin-dependent signaling pathway J Biol Chem 277,
27975–27981.
25 Gingras, A.C., Raught, B & Sonenberg, N (2001)Regulation of
translation initiation by FRAP/mTOR Genes Dev 15, 807–826.
26 Fukuda, R., Hirota, K., Fan, F., Jung, Y.D., Ellis, L.M &
Semenza, G.L (2002)IGF-1 induces HIF-1-mediated VEGF
expression that is dependent on MAP kinase and PI-3-kinase
signaling in colon cancer cells J Biol Chem 277, 38205–38211.
27 Minet, E., Arnould, T., Michel, G., Roland, I., Mottet, D., Raes,
M., Remacle, J & Michiels, C (2000)ERK activation
upon hypoxia: involvement in HIF-1 activation FEBS Lett.
468, 53–58.
28 Mazure, N.M., Chen, E.Y., Laderoute, K.R & Giaccia, A.J.
(1997)Induction of vascular endothelial growth factor by hypoxia
is modulated by a phosphatidylinositol 3-kinase/Akt signaling
pathway in Ha-ras- transformed cells through a hypoxia inducible
factor-1 transcriptional element Blood 90, 3322–3331.
29 Conrad, P.W., Freeman, T.L., Beitner-Johnson, D & Millhorn,
D.E (1999)EPAS1 trans-activation during hypoxia requires p42/
p44 MAPK J Biol Chem 274, 33709–33713.
30 Huang, L.E., Arany, Z., Livingston, D.M & Bunn, H.F (1996)
Activation of hypoxia-inducible transcription factor depends
primarily upon redox-sensitive stabilization of its alpha subunit.
J Biol Chem 271, 32253–32259.
31 Semenza, G.L (2001)HIF-1 and mechanisms of hypoxia sensing.
Curr Opin Cell Biol 13, 167–171.
32 Haddad, J.J (2002)Recombinant human interleukin
(IL)-1beta-mediated regulation of hypoxia-inducible factor-1alpha
(HIF-1alpha)stabilization, nuclear translocation and activation
requires an antioxidant/reactive oxygen species (ROS)-sensitive
mechanism Eur Cytokine Netw 13, 250–260.
33 Huang, R.P., Wu, J.X., Fan, Y & Adamson, E.D (1996)UV
activates growth factor receptors via reactive oxygen
intermediates J Cell Biol 133, 211–220.
34 Saltiel, A.R & Kahn, C.R (2001)Insulin signalling and the
regulation of glucose and lipid metabolism Nature 414, 799–806.
35 Agani, F & Semenza, G.L (1998)Mersalyl is a novel inducer of
vascular endothelial growth factor gene expression and
hypoxia-inducible factor 1 activity Mol Pharmacol 54, 749–754.
36 Hofer, T., Desbaillets, I., Hopfl, G., Gassmann, M & Wenger,
R.H (2001)Dissecting hypoxia-dependent and
hypoxia-independent steps in the HIF-1a activation cascade: implications
for HIF-1a gene therapy FASEB J 15, 2715–2717.
37 Wang, G.L., Jiang, B.H & Semenza, G.L (1995)Effect of
protein kinase and phosphatase inhibitors on expression of
hypoxia-inducible factor 1 Biochem Biophys Res Commun.
216, 669–675.
38 Pugh, C.W., O’Rourke, J.F., Nagao, M., Gleadle, J.M &
Ratcliffe, P.J (1997)Activation of hypoxia-inducible factor-1;
definition of regulatory domains within the a subunit J Biol.
Chem 272, 11205–11214.
39 Gradin, K., Takasaki, C., Fujii-Kuriyama, Y & Sogawa, K.
(2002)The transcriptional activation function of the HIF-like
factor requires phosphorylation at a conserved threonine J Biol.
Chem 277, 23508–23514.
40 Jewell, U.R., Kvietikova, I., Scheid, A., Bauer, C., Wenger, R.H.
& Gassmann, M (2001)Induction of HIF-1a in response to
hypoxia is instantaneous FASEB J 15, 1312–1314.
41 Richard, D.E., Berra, E., Gothie, E., Roux, D & Pouyssegur, J.
(1999)p42/p44 mitogen-activated protein kinases phosphorylate
hypoxia-inducible factor 1a (HIF-1a)and enhance the transcriptional activity of HIF-1 J Biol Chem 274, 32631–32637.
42 Sodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E.A & Gutkind, J.S (2000)The Kaposi’s sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1a Cancer Res 60, 4873–4880.
43 O’Rourke, J.F., Tian, Y.M., Ratcliffe, P.J & Pugh, C.W (1999) Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1a J Biol Chem 274, 2060–2071.
44 Mahon, P.C., Hirota, K & Semenza, G.L (2001)FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity Genes Dev 15, 2675– 2686.
45 Lando, D., Peet, D.J., Gorman, J.J., Whelan, D.A., Whitelaw, M.L & Bruick, R.K (2002)FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor Genes Dev 16, 1466–1471.
46 Stiehl, D.P., Jelkmann, W., Wenger, R.H & Hellwig-Burgel, T (2002)Normoxic induction of the hypoxia-inducible factor 1a by insulin and interleukin-1b involves the phosphatidylinositol 3-kinase pathway FEBS Lett 512, 157–162.
47 Zimmer, S.G., DeBenedetti, A & Graff, J.R (2000)Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as
a central regulator of tumor formation, growth, invasion and metastasis Anticancer Res 20, 1343–1351.
48 Wiener, C.M., Booth, G & Semenza, G.L (1996) In vivo expression of mRNAs encoding hypoxia-inducible factor 1 Biochem Biophys Res Commun 225, 485–488.
49 Epstein, A.C., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O’Rourke, J., Mole, D.R., Mukherji, M., Metzen, E., Wilson, M.I., Dhanda, A., Tian, Y.M., Masson, N., Hamilton, D.L., Jaakkola, P., Barstead, R., Hodgkin, J., Maxwell, P.H., Pugh, C.W., Schofield, C.J & Ratcliffe, P.J (2001) C elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation Cell 107, 43–54.
50 Kallio, P.J., Wilson, W.J., O’Brien, S., Makino, Y & Poellinger,
L (1999)Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway J Biol Chem 274, 6519–6525.
51 Chan, D.A., Sutphin, P.D., Denko, N.C & Giaccia, A.J (2002) Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha J Biol Chem 277, 40112–40117.
52 Palmer, L.A., Gaston, B & Johns, R.A (2000)Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides Mol Pharmacol 58, 1197–1203.
53 Kourembanas, S., McQuillan, L.P., Leung, G.K & Faller, D.V (1993)Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia J Clin Invest 92, 99–104.
54 Liu, Y., Christou, H., Morita, T., Laughner, E., Semenza, G.L.
& Kourembanas, S (1998)Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5¢ enhancer J Biol Chem 273, 15257– 15262.
55 Huang, L.E., Willmore, W.G., Gu, J., Goldberg, M.A & Bunn, H.F (1999)Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide Implications for oxygen sensing and signaling J Biol Chem 274, 9038–9044.
56 Melillo, G., Musso, T., Sica, A., Taylor, L.S., Cox, G.W & Varesio, L (1995)A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter J Exp Med 182, 1683–1693.
Trang 857 Lee, P.J., Jiang, B.H., Chin, B.Y., Iyer, N.V., Alam, J., Semenza,
G.L & Choi, A.M (1997)Hypoxia-inducible factor-1 mediates
transcriptional activation of the heme oxygenase-1 gene in
response to hypoxia J Biol Chem 272, 5375–5381.
58 Zeng, G & Quon, M.J (1996)Insulin-stimulated production of
nitric oxide is inhibited by wortmannin Direct measurement in
vascular endothelial cells J Clin Invest 98, 894–898.
59 Wang, F., Sekine, H., Kikuchi, Y., Takasaki, C., Miura, C.,
Heiwa, O., Shuin, T., Fujii-Kuriyama, Y & Sogawa, K (2002)
HIF-1a-prolyl hydroxylase: molecular target of nitric oxide in the
hypoxic signal transduction pathway Biochem Biophys Res.
Commun 295, 657–662.
60 Zhong, H., Agani, F., Baccala, A.A., Laughner, E.,
Rioseco-Camacho, N., Isaacs, W.B., Simons, J.W & Semenza, G.L (1998)
Increased expression of hypoxia inducible factor-1a in rat and
human prostate cancer Cancer Res 58, 5280–5284.
61 Stroka, D.M., Burkhardt, T., Desbaillets, I., Wenger, R.H., Neil,
D.A., Bauer, C., Gassmann, M & Candinas, D (2001)HIF-1 is
expressed in normoxic tissue and displays an organ-specific
regulation under systemic hypoxia FASEB J 15, 2445–2453.
62 Faller, D.V (1999)Endothelial cell responses to hypoxic stress.
Clin Exp Pharmacol Physiol 26, 74–84.
63 Kuwabara, K., Ogawa, S., Matsumoto, M., Koga, S., Clauss, M.,
Pinsky, D.J., Lyn, P., Leavy, J., Witte, L., Joseph-Silverstein, J.
et al (1995)Hypoxia-mediated induction of acidic/basic fibroblast
growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells Proc Natl Acad Sci USA 92, 4606–4610.
64 Gleadle, J.M., Ebert, B.L., Firth, J.D & Ratcliffe, P.J (1995) Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents Am J Physiol 268, C1362–C1368.
65 Imagawa, M., Tsuchiya, T & Nishihara, T (1999)Identification
of inducible genes at the early stage of adipocyte differentiation of 3T3-L1 cells Biochem Biophys Res Commun 254, 299–305.
66 Constancia, M., Hemberger, M., Hughes, J., Dean, W., Ferguson-Smith, A., Fundele, R., Stewart, F., Kelsey, G., Fowden, A., Sibley,
C & Reik, W (2002)Placental-specific IGF-II is a major modulator of placental and fetal growth Nature 417, 945–948.
67 Albina, J.E., Mastrofrancesco, B., Vessella, J.A., Louis, C.A., Henry, W.L Jr & Reichner, J.S (2001)HIF-1 expression in healing wounds: HIF-1a induction in primary inflammatory cells
by TNF-a Am J Physiol Cell Physiol 281, C1971–C1977.
68 Mathupala, S.P., Rempel, A & Pedersen, P.L (2001)Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions J Biol Chem 276, 43407–43412.
69 Dang, C.V., Lewis, B.C., Dolde, C., Dang, G & Shim, H (1997) Oncogenes in tumor metabolism, tumorigenesis, and apoptosis.
J Bioenerg Biomembr 29, 345–354.